Thursday, Feb. 16, 7:30 a.m.-7 p.m.
Renaissance Denver Downtown City Center Hotel, Denver, CO
Join hundreds of investors from throughout North America at Destination Startup®. This showcase demonstrates a powerful way to advance innovative research and translate it into impactful business ventures. The February 2023 showcase returns as a fully in-person event.
BizWest—CU Ƶ startup LongPath Technologies is the first emissions-monitoring technology to be approved by both the Environmental Protection Agency (EPA) and the Colorado Department of Public Health & Environment (CDPHE).
Reuters, Bloomberg, more—CU Ƶ spinout Solid Power announced it would offer intellectual property rights related to its solid-state batteries to BMW and allow the production of the battery cells at the automaker's facilities in Germany.
PV Magazine—Brek Electronics, a CU Ƶ spinout, has developed two string inverters with its novel composite architecture optimized for silicon carbide (SiC) components.
<p>CU Ƶ spinout Inscripta®, a global leader in genome engineering technology, announced the acquisition of two pioneers of synthetic biology—Infinome Biosciences and Sestina Bio, which advance Inscripta’s strategy to develop and commercialize bio-manufactured products for a broad spectrum of industrial and consumer markets. </p>
CU Ƶ spinout InDevR Inc, a provider of analytical technologies for vaccines and biotherapeutics, announced that it has raised $9 million in series B financing. Adjuvant Capital has invested $4 million, and bioMérieux $5 million. Together, these investments will support InDevR’s commercial expansion and ongoing development of new reagent kits for its VaxArray® platform.
TechCrunch—Meati Foods, a CU Ƶ spinout, is closer to full-scale production of its whole-food protein made from the structural fibers of mushrooms, known as mycelium. The company announced Thursday the opening of its production facility, dubbed “Mega Ranch,” in Colorado.
Forbes—CU Ƶ startup Inscripta, a global leader in genome engineering, is reshaping the image of a synthetic biology company. Biomanufacturing is set to transform many industries by making the products that the world needs cleaner, more efficient and more sustainable.
Professor Joel Kaar’s research group has modified enzymes with co-polymers. By tuning the composition of the co-polymer, one can tune the solubility of the enzyme polymer conjugate in non-aquaeous solution, while still retaining the activity of the enzyme.
Research teams led by Dr. Chris Lowry of CU Ƶ and Dr. Thomas Keck of Rowan University are investigating the translational potential of a novel immunotherapy for its potential to reduce relapse-like and addictive behavior associated with cocaine use.
Upcoming Events and Opportunities
April 7, 14 and 21: Starting Blocks Customer Discovery Workshop—A three-day workshop with customer interviews designed to help scientists and engineers of all types find a market for their innovations. earn More